TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Most mutations that decreased antibiotic susceptibility were related to specific metabolic pathways. A MIC-increase to ...